Rafael Holdings, Inc. Class B (RFL): Price and Financial Metrics
RFL Price/Volume Stats
| Current price | $1.91 | 52-week high | $2.50 |
| Prev. close | $2.03 | 52-week low | $1.29 |
| Day low | $1.90 | Volume | 36,700 |
| Day high | $2.04 | Avg. volume | 28,469 |
| 50-day MA | $1.92 | Dividend yield | N/A |
| 200-day MA | $1.67 | Market Cap | 47.13M |
RFL Stock Price Chart Interactive Chart >
Rafael Holdings, Inc. Class B (RFL) Company Bio
Rafael Holdings, Inc., through its subsidiary, manufactures metabolic oncology drugs to treat cancer. The company also owns and operates real estate properties. The company was incorporated in 2017 and is based in Newark, New Jersey. Rafael Holdings, Inc. operates as a subsidiary of IDT Corporation
RFL Price Returns
| 1-mo | 1.60% |
| 3-mo | 32.64% |
| 6-mo | N/A |
| 1-year | 3.80% |
| 3-year | -69.49% |
| 5-year | -89.47% |
| YTD | 4.37% |
| 2023 | -2.14% |
| 2022 | -63.33% |
| 2021 | -78.13% |
| 2020 | 30.72% |
| 2019 | 124.97% |
Continue Researching RFL
Want to see what other sources are saying about Rafael Holdings Inc's financials and stock price? Try the links below:Rafael Holdings Inc (RFL) Stock Price | Nasdaq
Rafael Holdings Inc (RFL) Stock Quote, History and News - Yahoo Finance
Rafael Holdings Inc (RFL) Stock Price and Basic Information | MarketWatch
Loading social stream, please wait...